|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 39/395 | |
| C07K 16/28 |
| (11) | Number of the document | 2205277 |
| (13) | Kind of document | T |
| (96) | European patent application number | 08841962.7 |
| Date of filing the European patent application | 2008-10-22 | |
| (97) | Date of publication of the European application | 2010-07-14 |
| (45) | Date of publication and mention of the grant of the patent | 2017-07-26 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/DK2008/050256 |
| Date | 2008-10-22 |
| (87) | Number | WO 2009/052830 |
| Date | 2009-04-30 |
| (30) | Number | Date | Country code |
| 200701519 | 2007-10-22 | DK |
| (72) |
GOLAB, Jakub, PL
WINIARSKA, Magdalena, PL
PARREN, Paul, NL
MACKUS, Wendy, NL
ENGELBERTS, Patrick, NL
|
| (73) |
Genmab A/S,
Bredgade 34 E, 1260 Copenhagen K,
DK
|
| (54) | NOVEL ANTIBODY THERAPIES |
| NOVEL ANTIBODY THERAPIES |